Laboratory Services


Authorities order B2C retailers to halt antibody test sales

Regulatory body Public Health England (PHE) has ordered telehealth player Babylon to stop selling B2C antibody tests until it has established their accuracy. Supplier Abbott has already said that the test is not suitable for home sample collection but players are still scrambling to sell in what's likely to be a multi-billion market.

New players threaten to disrupt lab market

Will Covid-19 be a game changer for the lab sector? The prospect of big government contracts and a massive, unserved B2C market is drawing new players into the diagnostic lab sector. Could they have a permanent impact?

Synlab raises €850m through bond

Pan-European lab group Synlab has issued over twice the amount of bond debt it was targeting in response to an low take-up of its bond-to-loan offer.

Bioatriki founder dies of COVID-19

Evangelos Spanos, the founder of Greece's largest private primary care and diagnostics chain, has died from COVID-19. What's next for Bioatriki?

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]

Who is raising money?

Making sense of the money markets isn't easy right now. But some big players - Ramsay, Zur Rose and TPG are still raising money and some sectors such as German outpatient are still seeing M&A consolidation.

Revenue halves for lab groups

HBI understands that lab groups across Europe are seeing revenue drops of 50% despite having extensive participation in COVID-19 testing. 

Medsi’s parent company develops new test for COVID-19

Sistema, the conglomerate which owns Russia's largest private healthcare group Medsi, has developed a test through its biotech arm which can be rolled out across Medsi's clinics. It may be one of the only major private healthcare providers anywhere which is under the same ownership umbrella as a biotech company developing new tests.

Find Us